S
uccessful vaccines mediate protection via neutralizing Abs (1, 2) . Parenteral routes of immunization are very efficient in inducing neutralizing IgG responses that can be maintained as humoral immunological memory over long periods of time (3, 4) . However, these routes usually induce poor IgA responses, especially at mucosal surfaces. For this reason, intranasal (i.n.) 2 administration might be an attractive route of vaccination, because in addition to inducing specific IgG responses this route also efficiently induces IgA responses at mucosal surfaces, which are the primary sites of pathogen entrance.
The regulation of IgA isotype class switch recombination (CSR) is complex, and both T cell-dependent (TD) and T cell-independent (TI) mechanisms have been described (5, 6) . IgA responses induced by TD Ags such as proteins require CD4 ϩ T cell help mediated by CD40 ligand (CD40L) as well as TGF␤1 and are mainly mediated by B2 B cells. In contrast, IgA responses induced by TI type 1 Ag (TI-1) such as LPS or TI type 2 Ag (TI-2) such as polysaccharides do not require CD40-CD40L interaction. Instead, they rely on APRIL (a proliferation-inducing ligand; secreted mainly by activated dendritic cells (DCs) and macrophages) binding to TACI (transmembrane activator, calcium modulator, and cyclophilin ligand interactor) on B cells and are mediated mainly by B1 B cells (7, 8) .
Both TD and TI mechanisms of CSR have been described for intestinal IgA production. Specifically, it has been shown that IgA CSR in the gut can occur independently of CD40 signaling and germinal center formation (9) . Retinoic acid has also been implicated in TI IgA responses and can stimulate the expression of gut-homing receptors on B cells. In addition, by synergizing with GALT-DC-derived IL-6 and IL-5, retinoic acid can promote IgA secretion (10) . Recently, NO secreted by DCs has also been implicated in the regulation of IgA production in the gut (7) .
In contrast to the gut, much less is known about the mechanisms controlling IgA responses at the respiratory mucosa. One of the few examples studied is influenza virus infection, where virusspecific IgA responses generated in the respiratory tract occurred independently of cognate T-B interaction (CD40 expression on B cells) but did require bystander CD4 ϩ T cell help in contrast to IgM and IgG responses, which were dependent on cognate interactions (11) .
Many reports have investigated the role of TLR signals in B cell responses, including memory B cell responses (12, 13) as well as CSR and induction of IgG Abs (14 -20) . The role of TLR signals in the induction of IgA responses is a subject of investigation. The Medzhitov group has detected normal levels of serum IgA in MyD88 Ϫ/Ϫ mice, suggesting that TLR signaling is dispensable for IgA responses (16) . However, more recently it was shown that TLR stimulation either on gut DCs (7) or in intestine epithelial cells (21) promotes IgA responses both in sera and intestinal content, indicating a potential role for TLR and MyD88 in regulating IgA responses.
Virus-like particles (VLPs) are highly effective immunogens that can induce strong Ab responses. VLPs are classic TI type 1 Ags that are able to induce IgM responses in the absence of T help because of multimeric interactions with cognate BCRs, which induce a strong activation signal in B cells. In addition, we have previously shown that i.n. and s.c. immunization with VLPs derived from the bacteriophage Q␤, Q␤-VLPs (22) , are efficient immunization routes for the induction of IgA responses (23) . Q␤-VLPs are packaged with RNA derived from Escherichia coli during its self-assembly process. Thus, Q␤-VLPs typically mediate TLR3/7 signals that we considered to be important candidates for triggering IgA responses.
In the present study, we assessed the role of TLR7 signaling in driving IgA responses to Q␤-VLPs both at the systemic level and in the respiratory tract mucosa. We found that depending on the site of Ag sampling, TLR7 signaling was required either to lung DCs and alveolar macrophages or to B cells and resulted in TD vs TI IgA responses, respectively. (where BCMA is B cell maturation Ag) were generated at and provided by Biogen Idec (32) . All animals were kept under specific pathogen-free conditions at BioSupport and were used at 8 to 12 wk of age. Experiments were conducted in accordance with protocols approved by the Swiss Federal Veterinary Office (Bern, Switzerland).
Materials and Methods

Mice
Immunization and Ag
To evaluate the Ab response induced by Q␤-VLP, C57BL/6, TLR7 For i.n. immunization with Q␤-VLP, mice were anesthetized with isoflurane and vaccine was administered using a 200-l pipette. The s.c. vaccination was performed by Q␤-VLP injection into both sides of the abdomen. For both routes of immunization, Q␤-VLP was diluted in PBS to a final administration volume of 100 l (2 ϫ 50 l).
Capsids of the RNA phage Q␤ were cloned into the pQ␤10 vector and purified as described elsewhere (22) . The AP205 coat protein (33) was cloned into the pQ␤10 vector (34) and expressed and purified similarly as Q␤.
ELISA
ELISA plates (Nunc-Immuno MaxiSorp; Nunc) were coated overnight with 100 l of Q␤-VLP (1 g/ml) and ELISA was performed according to standard protocols using the following HRP-conjugated secondary Abs: goat anti-mouse IgG (Fc␥ specific; Jackson ImmunoResearch); goat antimouse IgA (␣-chain specific; Sigma-Aldrich); rat anti-mouse IgG1 (BD Pharmingen); and rat anti-mouse IgG2a (BD Pharmingen).
For detection of anti-Q␤-VLP IgA in serum, IgG was depleted using protein G (GE Healthcare). ELISA controls showed that the elevated amount of anti-Q␤-VLP IgG in serum suppresses the measurement of anti-Q␤-VLP IgA. For detection of anti-Q␤-VLP IgG and Q␤-VLP IgA in bronchoalveolar lavage (BAL), undiluted samples were used. Anti-Q␤-VLP IgG titers in serum and in BAL are indicated as dilutions reaching half-maximal absorbance at 450 nm. Anti-Q␤-VLP IgA titers in serum and in BAL were measured by endpoint titer by calculating the OD (450 nm) cutoff as the average of the OD of the naive sample multiplied by 3-fold the SD of the OD of the naive sample.
ELISPOT assay
Q␤-VLP-specific, Ab-forming cell (AFC) frequencies were determined as described (35) . Briefly, 24-well plates were coated with 10 g/ml Q␤-VLP. Spleen and mediastinal LN (MLN) were added in DMEM containing 2% FCS and incubated for 5 h at 37°C. Cells were washed off and plates were incubated with either goat anti-mouse IgG (EY Laboratories) or goat antimouse IgA (␣-chain specific; Southern Biotech), followed by alkaline phosphatase-conjugated donkey anti-goat IgG Ab (Jackson ImmunoResearch Laboratories) before the development of alkaline phosphatase color reactions.
Radiation bone marrow chimeras
Radiation BM chimeras in which all B cells were deficient in the expression of TLR7 were generated by i.v. injection of BM mixture containing 20% of BM cells isolated from TLR7
Ϫ/Ϫ mice and 80% of BM cells isolated from JH Ϫ/Ϫ mice (1-5 ϫ 10 7 total injected cells) into JH Ϫ/Ϫ mice that had been lethally irradiated (950 rad) 1 day previously. Before cell transfer, BM cell suspension was depleted from T cells. Control chimeras with wild-type (WT) B cells were made using a combination of C57BL/6 and JH Ϫ/Ϫ donor BM. After 6 wk, BM reconstitution was assessed by staining peripheral blood lymphocytes. Thereafter, mice were immunized with 100 g of Q␤-VLP either i.n. or s.c.
The BM chimeras in which CD11c ϩ cells lack TLR7 expression were generated as follows. WT mice were lethally irradiated and reconstituted with a BM mixture containing 50% of BM cells isolated from TLR7 Ϫ/Ϫ mice and 50% of BM cells isolated from CD11c-DTR mice. Control chimeras were generated using a mixture of BM cells isolated from C57BL/6 and CD11c-DTR mice. For CD11c ϩ cells ablation, diphtheria toxin was administered i.n. for 5 days. In the first three administrations (every day) the mice received 100 ng of diphtheria toxin (DT). For the last two administrations (with a 1-day interval), only 50 ng of DT was inoculated. AP205-VLP, similar to Q␤-VLP in that they are phage derived, loaded with E. coli RNA, and exhibit similar sizes, were used for immunization. Mice were immunized i.n. with 100 g of AP205-VLP 24 h after the first DT administration.
Lung washes and lung digestion
BAL samples were collected through the trachea by washing the lung three times with 300 l of PBS plus 1% BSA. Samples were stored at Ϫ20°C until use.
For the isolation of leukocytes from the lung, mice were perfused with 5-10 ml of PBS in the heart ventricle to clear the lungs of blood. Lungs were chopped in small pieces and incubated at 37°C in medium containing collagenase (2.4 mg/ml). Finally, leukocytes were harvested by using a 30% Percoll gradient.
Flow cytometry
For detecting cells in association with Q␤-VLP, mice were immunized either i.n. or s.c. with Q␤-VLP labeled with Alexa Fluor 488. Twentyfour or 4 h after immunization the mice were killed and cells isolated from lung and MLNs were stained with allophycocyanin-conjugated rat anti-mouse CD11b and PE-conjugated hamster anti-mouse CD11c (BD Pharmingen). In all cases, Fc receptors were blocked with rat IgG2b anti-mouse CD16/32 (2.4G2) and dead cells were excluded by propidium iodide staining.
Quantitative real-time PCR
Synthesis of ss-cDNA was done with total RNA using random nonamers (Microsynth) and SuperScript II reverse transcriptase (Invitrogen) according to the manufacturer's protocol. Complementary RNA was digested by treating the ss-cDNA with 2 U of RNase H (New England Biolabs) at 37°C for 20 min. The cDNA was then used as template for real-time quantitative PCR (iCycler instrument; Bio-Rad) with the gene-specific primers ␤-actin-F (5Ј-CCCTGAAGTACCCCATTGAAC-3Ј), ␤-actin-B (5Ј-CTTTT CACGGTTGGCCTTAG-3Ј), APRIL-F (5Ј-GGGGAAGGAGTGTCAGA GTG-3Ј), APRIL-B (5Ј-GCAGGGAGGGTGGGAATAC-3Ј), BAFF-F (5Ј-AGGCTGGAAGAAGGAGATGAG-3Ј), and BAFF-B (5Ј-CAGAG AAGACGAGGGAAGGG-3Ј) (where BAFF stands for B cell-activating factor of the TNF family, F stands for forward, and B stands for backwards) using Brilliant SYBR Green QPCR Master Mix (Stratagene) according to the manufacturer's protocol.
Results
Site of Ag exposure governs the requirement for T cell cognate help during IgA production
VLPs are classified as TI type 1 (TI-1) Ag because they can efficiently induce IgM responses without the need of T cell help. This property can be accredited to their highly organized structure, which allows them to efficiently crosslink the BCR. At the same time they can behave as a TD Ag, because they are proteins. Indeed, we have observed that Q␤-specific IgM responses are induced in the absence of T cell help, whereas specific IgG responses required the cognate interaction between T and B cells (19, 36) . In this study we assessed whether the IgA response against Q␤-VLP would require T cell help or whether, similarly as the IgM response, IgA could also be induced by a TI mechanism. To address this question, we immunized WT and MHC II Ϫ/Ϫ mice via the i.n. or s.c. routes and compared the mucosal (BAL) and systemic (serum) IgA titers, respectively, between the two groups. The mucosal IgA response in MHC II Ϫ/Ϫ mice immunized i.n. was strongly reduced compared with WT mice. In marked contrast, the levels of systemic IgA were similar for MHC II Ϫ/Ϫ and WT mice immunized s.c. (Fig. 1A) . We further assessed the IgA response elicited in CD40 Ϫ/Ϫ mice. In accordance with our findings in MHC II Ϫ/Ϫ mice, mucosal IgA levels in CD40 Ϫ/Ϫ mice were also significantly reduced compared with the WT group, whereas the systemic IgA titer elicited in CD40 Ϫ/Ϫ mice immunized s.c. was comparable to that of the WT group (Fig. 1B ). These observations show that IgA responses against Q␤-VLP are differentially regulated depending on the site of Ag exposure. Whereas mucosal IgA responses elicited upon mucosal administration of VLPs in the lung requires T cell help and the cognate interaction between T and B cells, Q␤-VLPs administered s.c. induced a TI systemic IgA response. As expected, the IgG response was strongly reduced in the absence of T cell help, independently of the route of immunization (data not shown).
It has been previously shown that a high Ag dose can be trapped in the splenic marginal zone and induce TI Ab responses (37) . We therefore assessed whether the TD IgA observed after i.n. immunization was not simply reflecting the low dose of Ag sampled following this immunization route. To address this hypothesis, we administered high doses of Q␤-VLP i.n. and measured IgA titers in BAL and serum. Fig. 2A shows that no Q␤-VLP-specific IgA could be detected in BAL of MHC II Ϫ/Ϫ mice, even when 1 mg of Q␤-VLP was administered. In serum, we observed that low levels of IgA could be induced in MHC II Ϫ/Ϫ mice following a high Ag dose (Fig. 2B ). This low TI IgA titer in serum might be due to some Ag leakage in the blood circulation following a high dose of Q␤-VLP i.n. (our unpublished data). Importantly, the TI IgA titer following 1 mg of Q␤-VLP was significantly lower compared with the TD IgA induced with only 50 g of Q␤-VLP. Thus, the T cell help dependency for the induction of IgA following i.n. immunization is not due to the impact of the Ag dose. In contrast to the IgA response, the Q␤-VLP-induced IgM response in serum was almost completely TI, corroborating the notion that the regulation of IgA Abs is governed by a different mechanism than IgM responses (Fig. 2C) .
Differential requirements for TGF␤ and TACI signaling for mucosal and systemic TI IgA production
TGF␤ is the major cytokine involved in the induction of IgA CSR. In vitro, TGF␤ has been shown to be involved in the Th-dependent CSR to IgA (7, 38) . Evidence for its in vivo role was provided by experiments showing that mice deficient for the TGF␤ receptor T␤RII selectively on B cells (T␤RII-B) were almost completely devoid of IgA, both in serum and in mucosal washes (39, 40) . In an attempt to address the role of TGF␤ in the IgA responses against Q␤-VLP in vivo, we used these T␤RII-B mice. Following s.c. immunization, systemic IgA responses in T␤RII-B mice were not significantly reduced compared with the control group. In contrast, the mucosal IgA titer in BAL of T␤RII-B mice was significantly lower when compared with that of control mice. This demonstrates that the systemic TI IgA response to Q␤-VLP is not dependent on TGF␤ signaling to B cells, whereas TGF␤ plays an important role for the induction of mucosal IgA response (Fig. 3A) .
IgA-specific CSR can be accomplished by TD or TI mechanisms. The TD mechanism requires CD40L expressed on activated T cells, whereas the TI mechanism is thought to rely largely on APRIL, a proliferation-inducing ligand, and BAFF, a B lymphocyte stimulator protein (also known as BLyS, TALL-1, THANK, and zTNF4), produced by DCs that interact with their cognate receptors, TACI and BCMA, expressed on B cells (8, 41) . To address the role of these molecules in Q␤-VLP-specific IgA responses, we compared the IgA levels in serum between the WT and TACI;BCMA double-deficient mice. Surprisingly, the systemic TI IgA levels in TACI; BCMA Ϫ/Ϫ mice were not significantly reduced compared with those in the WT group. In contrast, the mucosal IgA response in the BAL of TACI;BCMA Ϫ/Ϫ mice was strongly reduced. Thus, in addition to requiring T cell help, local IgA responses also needed signaling through TACI or BCMA whereas TI systemic IgA responses occurred in a TACI/BCMA-independent manner (Fig. 3B) . To investigate whether TACI or BCMA signaling was required for mucosal IgA responses, we also administered Q␤-VLP i.n. to TACI Ϫ/Ϫ mice. Similarly as the double-deficient TACI;BCMA Ϫ/Ϫ mice, TACI Ϫ/Ϫ mice generated a significantly reduced IgA response in BAL (data not shown). This indicates that the TD IgA responses occurring at the airway mucosa require TACI-mediated signals.
TLR7 signaling is required for induction of optimal mucosal TD and systemic TI IgA responses against Q␤-VLP
Our previous data demonstrated that the mucosal IgA production in response to i.n. immunization required Th cell-derived signals (CD40L) in addition to TACI-mediated signals. In contrast, the systemic IgA response elicited by s.c. immunization did not require Th cells or TACI signaling. Thus, the IgA responses against VLPs are differentially regulated depending on the site of Ag exposure. We therefore sought to understand which additional factor, other than Th cells and TGF␤ and APRIL/BAFF production, could 
As mentioned, Q␤-VLPs are loaded with E. coli-derived ssRNA and provide efficient TLR7 stimulation. To determine whether TLR7 signaling played a role in regulating the IgA response, we compared the IgA and the IgG isotypes in the sera of mice immunized either i.n. or s.c. in the presence or absence of TLR7 and MyD88 signaling. To this end, we compared both the Ab response of mice immunized with Q␤-VLPs with or without packaged RNA and the response of WT mice to TLR7-or MyD88-deficient mice. As shown in Fig. 4, A and B , IgA and IgG2a in serum were only induced with Q␤-VLP containing RNA. In contrast, the levels of IgA and IgG2a in WT mice immunized with Q␤-VLP devoid of RNA as well as in TLR7
Ϫ/Ϫ and MyD88 Ϫ/Ϫ mice were very low. Following s.c. immunization, IgG1 responses were induced in the absence of TLR7 signaling and suppressed by the presence of TLR7 signaling, which confirms previous findings for TLR9 signaling (19) . In contrast, TLR7 signaling had no influence on specific IgG1 titers following i.n. immunization (Fig. 4A) . In the BAL, similarly as the systemic Ab response, the levels of IgA and IgG2a were completely abolished in the absence of TLR7 signaling (Fig. 4C) .
The numbers of Q␤-VLP specific AFCs correlate with the Ab titer
We have previously seen that MLNs are the major inductive site of the Ab response upon i.n. immunization against Q␤-VLP (23). Next, the impact of TLR signaling on the number of AFCs secreting Q␤-VLP-specific IgA in these LNs was investigated. Similarly as the Ab titer, the number of AFCs secreting IgA was strongly reduced in mice immunized with VLP devoid of RNA as well as in TLR7
Ϫ/Ϫ and MyD88 Ϫ/Ϫ mice compared with control mice (Fig. 4D) . The same was true for the spleen of s.c. immunized mice (Fig. 4E) .
In conclusion, in contrast to T cell help, CD40L, TGF␤, and TACI, TLR7 signaling was pivotal for the induction of systemic IgA responses after s.c. immunization.
IgA CSR upon s.c. immunization requires TLR7 signaling directly on B cells
In the next set of experiments, we investigated how TLR7 signaling controls IgA responses to Q␤-VLP following i.n. and s.c. immunization. To this end, we reconstituted lethally irradiated WT C57BL/6 mice with MyD88 Ϫ/Ϫ BM such that hematopoietic cells lacked MyD88 expression, whereas its expression was normal in radiation-resistant cells such as epithelial cells. Irradiated WT mice reconstituted with MyD88 Ϫ/Ϫ BM cells failed to produce IgA upon i.n. immunization, suggesting that hematopoietic cells are responsible for regulating the IgA response to Q␤-VLP via TLR7 signaling (Fig. 5A) . We have previously shown that TLR9 signaling in B cells but not in non-B cells is essential for promoting IgG2a responses against VLPs loaded with CpGs (19) . We therefore assessed whether a similar mechanism regulated IgA CSR. We addressed this question by generating BM chimeras exhibiting TLR7 expression in all hematopoietic cells except B cells. To this end, B cell-deficient (JH Ϫ/Ϫ ) recipient mice were lethally irradiated and reconstituted with a mixture of BM cells isolated from JH Ϫ/Ϫ and TLR7 Ϫ/Ϫ mice or from JH Ϫ/Ϫ and WT mice. This model allowed us to generate chimeric mice containing only TLR7 WT or deficient B cells with all other hematopoietic cells derived from JH Ϫ/Ϫ mice expressing TLR7. Our results showed that signaling directly to B cells played a role in regulating systemic IgA responses against Q␤-VLP following s.c. immunization but was less important for mucosal IgA responses following i.n. immunization (Fig. 5, B and C) . This shows that TI systemic IgA CSR requires TLR7 signaling directly to B cells. In contrast, the impact of TLR7 signaling on mucosal IgA responses was due to an involvement of another hematopoietic cell type.
In a marked contrast, the Q␤-VLP-specific IgG2a titers, both in serum and BAL, were strongly reduced in the group of mice in which the B cells were TLR7 deficient (Figs. 5, B and C) . Based on this finding, we concluded that not only TLR9 and TLR4 signaling in B cells (13, 16, 19) but also TLR7 signaling controls IgG2a CSR independently of the immunization route and requires TLR7 expression in B cells. Importantly, IgG1 levels in chimeric mice exhibiting TLR7-deficient B cells were increased, demonstrating normal responsiveness of the B cells.
Taken together, we conclude that regardless of the immunization route, IgG2a CSR is governed by TLR signaling directly to B cells. In contrast, for IgA responses, this was the case only after s.c. immunization. Thus, IgG2a and IgA CSR are differently regulated.
Lung DCs and alveolar macrophages are the major cell populations transporting Q␤-VLP from the lung to the draining LN
TLR7 signaling directly to B cells was not required for mucosal IgA. Therefore, our next attempt was to identify the cell population requiring TLR7 signals to promote mucosal IgA responses. We have previously shown that upon i.n. administration, Q␤-VLP can mainly be found in the lung and that MLNs that drain the lower airways and are the major sites to which Q␤-VLPs are transported and where the Ab response is initiated (23) .
To elucidate which cell population may be involved in TLR7-dependent IgA CSR, we analyzed in detail the cellular populations interacting with Q␤-VLP within the lung and the MLNs. It has been shown previously that in the lung, CD11c ϩ CD11b Ϫ cells are alveolar macrophages whereas CD11c ϩ CD11b ϩ cells are lung DCs (42) . By analyzing Q␤ ϩ cells in the lung, we observed that most of the Q␤ ϩ cells were CD11c ϩ CD11b Ϫ cells and a minor proportion were CD11c ϩ CD11b ϩ cells, identifying the major cell population interacting with Q␤-VLPs as alveolar macrophages (Fig. 6A) . We also found a few Q␤-VLPs in association with CD11c Ϫ CD11b ϩ cells and B cells in the lung (Fig. 6A and data not shown). In MLNs of mice that received Q␤-VLPs i.n., the two major cell populations bearing Q␤-VLPs were again alveolar macrophages and DCs (Fig. 6B) . Almost no CD11c Ϫ CD11b ϩ cells positive for Q␤-VLPs were found in MLNs, indicating that this cell population is nonmigratory and remains in the lung. Thus, it is possible that alveolar macrophages and DCs take up Q␤-VLPs in the lung, sense the endogenous ssRNA, and transport the Ag to MLNs. To address this question, we investigated what happens in a situation where alveolar macrophages and DCs are unable to migrate. In CCR7 Ϫ/Ϫ mice, these two cell populations were completely absent in the MLN, and most of Q␤-VLP was in association with CD11b ϩ cells. This finding suggests that in WT mice most Q␤-VLPs are carried to MLNs by alveolar macrophages and DCs, whereas in situations where these cells were unable to migrate (CCR7 Ϫ/Ϫ mice), Q␤-VLPs drained via the lymphatic system (Fig. 6B) .
Following s.c. administration, a large fraction of Q␤-VLPs enter the bloodstream and are distributed throughout the body (our unpublished data). By analyzing Q␤ ϩ cell populations in MLNs after s.c. immunization, we found that Q␤-VLP was in association with distinct cell populations such as macrophages, monocytes, and lymphocytes. Most strikingly, the alveolar macrophage (CD11c ϩ CD11b Ϫ ) population was completely absent in the Q␤-VLP ϩ gate (Fig. 6C and data not shown) .
By comparing the numbers of AFCs secreting Q␤-VLP-specific Abs in MLNs of i.n. and s.c. immunized mice, we observed that both groups elicited similar numbers of AFCs secreting anti-Q␤-VLP IgG; however, the numbers of AFCs secreting anti-Q␤-VLP IgA were significantly reduced in MLN of s.c. immunized mice (Fig. 6D) . This suggests that CD11c ϩ cells that take up Q␤-VLP and migrate to MLNs are the key cells for the induction of mucosal IgA responses.
TLR7 signaling in lung DCs and alveolar macrophages induces expression of APRIL and BAFF
Next, we sought to understand why the lack of TLR7 signaling in lung DCs and alveolar macrophages has implications in the mucosal IgA response against Q␤-VLP. We have seen that TLR7 signaling has only a minor impact in lung DC and alveolar macrophage migration to the MLNs (data not shown). Therefore, we anticipated that there must be another explanation for the need of TLR signaling in these cells to induce mucosal IgA responses. It has been shown that upon CpG and dsRNA stimulation, mucosal DCs increase BAFF and APRIL expression (7, 43) . We were therefore wondering whether ssRNA signaling via TLR7 expressed in lung DCs and alveolar macrophages has a similar effect. To address this question, we sorted the Q␤ ϩ cells from MLNs of WT and TLR7 Ϫ/Ϫ mice that received Q␤-VLP i.n. and compared the expression level of APRIL and BAFF. Fig. 7A shows that the levels of APRIL and BAFF were reduced 3-and 2-fold, respectively, in the Q␤ ϩ cells isolated from the TLR7 Ϫ/Ϫ mice when compared with the WT group. This result indicates that optimal BAFF and APRIL expression by lung DCs and alveolar macrophages occurs following TLR stimulation in vivo.
Alveolar macrophages and lung DCs sense ssRNA to induce optimal IgA response
To directly address the hypothesis that the CD11c ϩ cells found in association with Q␤-VLP in MLN of i.n. immunized mice are the cell population that requires TLR7 signals to promote IgA responses, we generated mixed BM chimeras using BM cells from CD11c-DTR-transgenic (CD11c-DTR) mice. CD11c-DTR mice have the CD11c promoter driving the expression of the monkey DTR, which allows the conditional depletion of CD11c ϩ cells following DT administration (30) . We therefore adopted this strategy to specifically deplete DCs and alveolar macrophages. Specifically, WT C57BL/6 mice were lethally irradiated and reconstituted with BM cells isolated from CD11c-DTR mice mixed with BM cells isolated from either TLR7 Ϫ/Ϫ or WT control mice. Upon DT administration, all members of the CD11c ϩ population in the chimeric mice completely lacked TLR7 signaling and therefore we could directly address the role of TLR7 signaling in these cells in inducing IgA responses. Fig. 7B shows that the levels of VLPspecific IgA in serum and BAL were reduced in chimeric mice in which DCs lack TLR7 expression, therefore confirming that TLR7 signaling in CD11c ϩ DCs and alveolar macrophages is pivotal in regulating mucosal IgA responses. 
Discussion
Most pathogens invade the body through the mucosa, and some cause local infections at mucosal sites. Secretory IgA plays a critical role in preventing infections at these sites. Furthermore, IgA is the most abundant Ig isotype in humans and understanding its regulation is of major importance.
In the present study we dissected the mechanisms involved in the regulation of IgA responses against Q␤-VLP administered via mucosal or systemic routes. Our data show that systemic IgA following s.c. immunization does not require Th cells or cognate interaction between T and B cells. In marked contrast, mucosal Q␤-VLP-specific IgA response in the lung was strongly dependent on T cell help. It has been shown that DCs can induce T cell-and CD40-independent CSR through BAFF and APRIL (44) . However, we observed in mice deficient for TACI and BCMA (TACI;BCMA Ϫ/Ϫ ) that BAFF and APRIL signaling were dispensable for the induction of systemic TI IgA titers in response to Q␤-VLP immunization. This finding contradicts the literature. Actually, it has been shown that systemic Ab responses elicited by 4-hydroxy-3-nitrophenylacetate (NP)-Ficoll (prototype TI-2 Ag) but not by NP-CGG (a TD Ag) are strongly regulated by TACI (45, 46) . This difference can be explained by differences in Ag nature, i.e., NP-Ficoll is a TI-2 Ag whereas VLP is a TI-1 Ag and therefore has a stronger capacity to generate B cell responses on its own. Another possibility is that the RNA present on VLPs overcomes the activation signals required via TACI. It still could be possible that BAFF-BAFF-R interaction plays a role in the regulation of TI systemic IgA responses. However, a major role has been attributed to signaling via TACI because TACI Ϫ/Ϫ mice have low serum IgA in response to TI type II Ags (45) . Furthermore,
APRIL
Ϫ/Ϫ mice also showed reduced systemic IgA in response to NP-LPS (a TI-1 Ag) (47) . Collectively, these data points to an important role of APRIL-TACI interaction in regulating TI IgA CSR and make it unlikely that BAFF-BAFF-R interaction is important to regulate the systemic TI IgA responses against VLPs.
In contrast to the systemic TI IgA responses, the TD IgA titers in BAL were significantly reduced in TACI;BCMA Ϫ/Ϫ mice as well as in TACI Ϫ/Ϫ mice. A dominant role for TACI confirms previous findings showing that TACI is important for mediating isotype switching and IgA production by B cells (48, 49) . Surprisingly, however, TACI was important for driving a TD IgA response rather than TI IgA responses. This is not consistent with the dogma that TACI mediates TI IgA CSR (45, 46) . Importantly, the mucosal IgA levels in BAL were completely abolished in both MHC II Ϫ/Ϫ as well as in CD40 Ϫ/Ϫ mice, whereas the reduction was only partial in TACI;BCMA Ϫ/Ϫ mice. This possibly indicates the synergistic role of Th cells and TACI signaling. Although, CD40-CD40L engagement is crucial for mucosal IgA CSR, TACI may be involved in IgA production and plasma cell survival. In agreement with this hypothesis, it has been recently shown that TACI enhances the differentiation of B cells into AFCs in cultures containing limiting conditions of CD40 ligation, suggesting that TACI may be important also for the Ab response to TD Ags (50) .
TGF␤ has been shown to be an important cytokine for IgA CSR in vitro (38, 51, 52) . In vivo, it was found that the IgA response, both in serum and in mucosal washes, against TD Ags was completely abolished in mice that lack TGF␤-RII in B cells (39, 40) . More recently, it was found that expression of TGF␤-RII on naive B cells is induced by inducible NO synthase (iNOS) with IgA CSR being impaired in iNOS Ϫ/Ϫ mice (7). However, the in vivo role of TGF␤ against viral particles had not yet been addressed. In the present study we found a significant reduction of Q␤-VLP-specific TD IgA titers in BAL of mice immunized i.n. that lack TGF␤RII in B cells, whereas systemic TI IgA levels were not significantly reduced. Thus, mucosal IgA responses to viral particles seem to depend on the one hand on TGF␤ and on the other hand on the presence of Th cells in addition to BAFF or APRIL secreted by DCs. In contrast, the induction of serum IgA upon systemic exposure to VLPs is largely independent of TGF␤. Furthermore, systemic IgA was independent of Th cells as well as signaling via TACI. These data indicate that there must be an additional, as yet undetermined, factor important for TI IgA CSR upon systemic exposure to viral particles. The fact that mice deficient in TGF␤RII expression in B cells previously have been shown to generate reduced IgA responses to chicken ␥-globulin (36) may reflect differences in Ag size (soluble protein vs VLP) or the absence of TLR ligands or may even be due to differences in the genetic background and/or rearing conditions that potentially affect the composition of the mucosal microbiota.
The role of TLR ligands as a third signal for Ab class switching has been previously described in vitro (17) . In vivo, several reports have indicated a role for TLR signaling in B cells as a IgG switching factor (13, 16, 18 -20) . However, the role of TLR signaling in regulating IgA responses has not been well studied. By comparing Q␤-VLP IgA titers in serum and BAL between groups of mice where TLR7 signaling was present or not, we found, unexpectedly, that TLR7 signaling had a crucial role in regulating IgA responses against Q␤-VLPs independently of the route of immunization. The same was true for IgG2a, but not for IgG1.
In accordance with this notion, other groups have also shown that microbial Ags are of ultimate importance in activating B cells and inducing IgA responses at both the serological and the mucosal level. Tezuka et al. reported that NO plays a crucial role in IgA class switching and secretion (7) . Interestingly, iNOS expression has been shown to be dependent on TLR stimulation, as DCs from germfree or MyD88 Ϫ/Ϫ mice express reduced levels of iNOS. Interestingly, it has been shown that BCR-deficient mice could develop a germinal center in the GALT (53). However, germinal centers failed to develop in mice maintained on antibiotics treatment, indicating a major dependence on the intestinal bacterial flora. More recently, it has also been shown that chronic epithelial TLR activation resulted in increased B cell recruitment and, consequently, fecal IgA content (21) .
Our experiments with BM chimeras demonstrated that TLR7 signaling in B cells was required for TI IgA CSR. Together with the notion that IgA responses under these conditions occur independently of Th cells, CD40, TGF␤, and TACI, we propose that TLR7 signaling directly to B cells may represent the missing factor required for TI IgA CSR. This fits with the idea that, following s.c. immunization, Q␤-VLP drains freely to bloodstream and reaches different lymphoid organs, including the spleen (our unpublished data). This might facilitate the direct interaction of Q␤-VLP with B cells. In contrast, mucosal IgA production requires TLR7 signaling by alveolar macrophages and lung DCs rather than directing TLR signaling to B cells. Thus, under these conditions, B cells may have little direct contact with VLPs, and IgA is induced indirectly, via CD40-CD40L, TGF␤-TGF␤RII, and APRIL/BAFF-TACI signaling. Indeed, APRIL and BAFF, the ligands for TACI, were up-regulated in alveolar macrophages and lung DCs upon TLR7 triggering (Fig. 8A) . These data are in contrast to a recent report showing that human upper respiratory mucosa B cells expressing TLR3 can initiate TI IgA response following dsRNA activation directly to B cells (43) . Perhaps soluble ssRNA not in association with viral particles also would trigger similar mechanism, because most likely it would target and be sampled by a cell population other than that of alveolar macrophages and lung DCs.
The observation that alveolar macrophages are a key population for induction of IgA seems counterintuitive, because macrophages are usually nonmigratory. Alveolar macrophages, however, seem to be different because it is an intrinsic feature of CD11c ϩ alveolar macrophages (42) to migrate to MLN and initiate immune responses against particulate Ags (54) . Our results have further demonstrated that alveolar macrophages migrate to the MLNs in a CCR7-dependent fashion. It will be interesting to directly distinguish in vivo the role of lung DCs and alveolar macrophages in regulating mucosal IgA responses against VLPs. Because different types of DCs and macrophages have distinct roles in the initiation and maintenance of immune responses (55) , it might well be that the mechanism described here is not applicable for IgA induction in other mucosal sites because alveolar macrophages and lung DCs are the cell populations restricted to the lung tissue.
In summary (Fig. 8 ), our data demonstrate that for TI systemic IgA responses, direct TLR7 signaling to B cells is crucial, whereas for TD mucosal IgA responses, regulation occurs indirectly through the ability of TLR7 signaling to activate alveolar macrophages and DCs, leading to increased BAFF and APRIL production, Th cell activation resulting in TGF␤ secretion, and delivery of CD40-CD40L cognate signals to B cells. It will be interesting to further determine whether this is a "unique" feature of TLR7 or whether other TLR agonists have similar properties. We have demonstrated for the first time that direct TLR signaling to B cells in combination with multivalent Ag results in TI IgA CSR.
